Skip to main content
. 2024 Mar 7;13(6):1531. doi: 10.3390/jcm13061531

Table 3.

Clinical characteristics of the included studies.

Study Location Disease Setting Sample Male/Female Age, Mean ± SD Technology/Body Part Total Training Hours (or Protocol) Type of Economic Cost Study
Hesse et al., 2014 [18] Germany Stroke Clinical setting 50 subacute stroke patients:
n = 25 (robot-assisted group therapy + individual arm therapy)
n = 25 (two sessions of individual arm therapy)
13/12
15/10
71.4 ± 15.5
69.7 ± 16.6
Robot/upper limb Experimental group: 30 min of robot therapy + 30 min of individual arm therapy per workday for four weeks; supervised by a therapy assistant
Control group: 2 × 30 min of individual arm therapy per workday for four weeks; supervised by an experienced therapist
Cost minimization
Cost benefit
Description of costs
Bustamante et al., 2016 [19] Mexico Stroke Clinical setting 20 chronic stroke patients:
n = 10 (traditional therapy)
n = 10 (Robot Gym)
4/6
3/7
64.1 ± 8.38
44.1 ± 12.55
Robot/upper limb and lower limb 24 two-hour therapy sessions over a period of 6 to 8 weeks for all study subjects Cost-effectiveness
Description of costs
McCabe et al., 2015 [20] USA Stroke Clinical setting 35 chronic stroke patients:
n = 11 (motor learning)
n = 12 (robot + motor learning)
n = 12 (FES + motor learning)
6/5
10/2
7/5
NR
NR
NR
Robot/upper limb 5 days/week for 5 h/day (60 sessions) for all groups Cost-effectiveness
Description of costs
Wagner et al., 2011 [21] USA Stroke Clinical setting 127 chronic stroke patients:
n = 49 (robot)
n = 50 (intensive comparison therapy)
n = 28 (usual care)
47/2
48/2
27/1
66 ± 11
64 ± 11
63 ± 12
Robot/upper limb Three 1 h sessions per week for 12 weeks, 36 sessions in total Cost minimization
Cost utility
Description of costs
Masiero et al., 2014 [22] Italy Stroke Clinical setting 35 acute stroke patients:
n = 17 (robot)
n = 18 (robot plus exercise with unimpaired upper limb)
21 acute stroke patients:
n = 11 (robot)
n = 10 (usual care)
30 acute stroke patients:
n = 14 (robot + usual care)
n = 16 (usual care)
10/7
11/7
9/2
7/3
10/4
10/6
63.4 ± 11.8
68.8 ± 10.5
72.4 ± 7.1
75.5 ± 4.8
65.6 ± 9.2
66.83 ± 7.9
Robot/upper limb Two daily sessions of 25 min each with robot, for 5 days per week. The two protocols were compared (in terms of number of weeks). Cost-effectiveness
Description of costs
Housley et al., 2016 [23] USA Stroke Home 20 chronic stroke patients:
n = 10 (upper limb robot)
n = 10 (lower limb robot)
9/1
10/0
63.4 ± 9.1
70.6 ± 12.7
Robot/upper limb and lower limb Each person was instructed to start at lower daily activity levels (one hour), progressing to the standard two-hour therapy dosage within the first week, which was continued for the three-month study duration. Due to the scheduling flexibility of the robotic device, participants were able to complete the two hours of daily prescribed robotic rehabilitation in any permutation. Cost utility
Cost benefit
Description of costs
Chan et al., 2022 [24] China Stroke Clinical setting NR NR NR Robot/lower limb NR Cost minimization

Cost benefit

Description of costs
Fernández-García et al., 2021 [25] UK Stroke Clinical setting 770 acute and chronic stroke patients:
n = 257 (robot-assisted training plus usual care)
n = 259 (EULT programme plus usual care)
n = 254 (usual care)
156/101
159/100
153/101
59.9 ± 13.5
59.4 ± 14.3
62.5 ± 12.5
Robot/upper limb Robot-assisted training: 45 min per day, three days per week for 12 weeks, in addition to usual care
EULT: 45 min per day, 3 days per week for 12 weeks, in addition to usual care
Usual care: 12-week period
Cost minimization
Cost-effectiveness
Cost utility
Description of costs
Rodgers et al., 2020 [26] UK Stroke Clinical setting 770 acute and chronic stroke patients:
n = 257 (robot-assisted training plus usual care)
n = 259 (EULT programme plus usual care)
n = 254 (usual care)
156/101
159/100
153/101
59.9 ± 13.5
59.4 ± 14.3
62.5 ± 12.5
Robot/upper limb Robot-assisted training: 45 min per day, three days per week for 12 weeks, in addition to usual care
EULT: 45 min per day, 3 days per week for 12 weeks, in addition to usual care
Usual care: 12-week period
Cost minimization
Cost effectiveness
Cost utility
Description of costs
Pinto et al., 2023 [27] USA Spinal cord injury Clinical setting 99 SCI patients:
n = 67 SCI patients (conventional training)
n = 32 SCI patients (overground robotic training)
46/21
20/12
42 ± 16
33 ± 13
Robot/lower limb Authors declared that “training was not standardized as is typical in practice-based evidence design”. Around 60 min for robotic intervention versus 45 min for the overground group. Donning and doffing of the robotic exoskeleton added non-therapeutic time (potentially 40 min). The overground robotic training group had greater training times. Cost utility
Description of costs
Lloréns et al., 2015 [28] Spain Stroke Clinical setting versus at home 30 chronic stroke patients:
n = 15 (in-clinic rehabilitation using VR)
n = 15 (at-home intervention using VR)
10/5
7/8
55.47 ± 9.63
55.60 ± 7.29
Virtual reality/lower limb Twenty 45 min training sessions conducted 3 times a week for 8 weeks. Both groups received conventional physical therapy in a clinic. Cost minimization
Description of costs
Islam et al., 2019 [29] Denmark, Norway and Belgium Stroke Clinical setting 102 subacute stroke patients:
n = 50 (VR training)
n = 52 (conventional training)
NR
NR
NR
NR
Virtual reality/upper limb Sixteen 60 min sessions over 4 weeks Cost minimization
Cost benefit
Description of costs
Adie et al., 2017 [30] UK Stroke Home 235 subacute stroke patients:
n = 117 (Wii ® intervention)
n = 118 (arm exercises at home)
66/51
65/53
66.8 ± 14.6
68.0 ± 11.9
Virtual reality/upper limb Daily sessions for six weeks Cost minimization
Cost benefit
Description of costs
Thomas et al., 2017 [31] UK Multiple sclerosis Home 30 MS patients (EDSS NR):
n = 15 (Nintendo Wii + usual care)
n = 15 (usual care)
1/14
2/13
50.9 ± 8.08
47.6 ± 9.26
Virtual reality/upper and lower limb 12 months and 6 months of treatment for each group, respectively. Rest of the protocol data were NR. Cost minimization
Description of costs
Farr et al., 2021 [32] UK Cerebral palsy Home 30 cerebral palsy patients (GMFCS levels I–II):
n = 15 (supervised VR group)
n = 15 (unsupervised VR group)
12/3
10/5
27% <11 years
27% >11 years
Virtual reality/lower limb 12 weeks of treatment (rest of the protocol data were NR). Cost minimization

EDSS: Expanded Disability Status Scale; GMFCS: Gross Motor Function Classification System; n: sample size; NR: not recorded; SD: standard deviation; SCI: spinal cord injury; VR: virtual reality.